Navigation Links
Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
Date:11/1/2007

SINGAPORE -- To mark its 100th year of advancing cancer research, the American Association for Cancer Research is holding Centennial Conferences in North America, Europe, and Asia. The AACR has teamed with the Genome Institute of Singapore and Singapores Agency for Science, Technology and Research (A*STAR) to hold the first of these conferences from November 4 to 8 in Singapore: the AACR Centennial Conference on Translational Cancer Medicine: From Technology to Treatment.

The conference will convene cancer research experts, scientists in training, and physicians from academia, industry, and government in Singapore to discuss emerging technologies that will enable the translation of laboratory discoveries into the practice of cancer medicine.

This meeting will foster the necessary dialogue to speed application of breakthrough laboratory discoveries to the practice of medicine. Translational cancer medicine provides the tools to build the connections needed to move practical knowledge from the laboratory to drug development to patient care, said William N. Hait, M.D., Ph.D., president of AACR, co-chairperson of the conference and senior vice president and head, worldwide hematology oncology research and development at Johnson and Johnson. By hosting this meeting in Singapore, not only are we expanding this discussion across international lines, but we are also highlighting the unique strengths of our Singapore colleagues as well as the challenges faced by researchers in response to the needs of Asian patients.

Specific topics will include advanced studies in cancer biology, genomics and molecular targets for future cancer drugs as well as the latest imaging, and high-throughput approaches to cancer detection, diagnosis, and treatment. The meeting will also explore questions specific to the region, such as the constraints and opportunities of cancer care delivery in Asia, and how best to tailor cancer treatment to the genetic profile of tumors found among Asian populations.

The early years of the 21st century no doubt will go down in history as a turning point in our efforts to improve the prevention and treatment of cancer through knowledge gained in the laboratory, said Edison Liu, Ph.D., executive director of the Genome Institute of Singapore, one of the 14 research institutes in the A*STAR collaborative. Translational research has become one of the most exciting areas of science at every major biomedical institution, from Singapore to Boston to London.


'/>"/>

Contact: Staci Vernick Goldberg
staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
3. Tamil Nadu Emerging As Model State In Public Health Care: Governor
4. Emerging Therapies for Skin Cancer Treatment
5. Emerging Research Heralds New Era of Breast Cancer Management
6. Emerging from the shadows of Breast Cancer
7. Law Emerging in US for Generic Versions of Biotech Medicine
8. Resistance Already Emerging in First Months of Treatment Despite Viral Load Decline
9. FDA Announces Audio Broadcasts on Emerging Drug Safety Information
10. Nutrient-rich Dairy Beverages an Emerging Market
11. Fire Ants are Emerging Nuisance for Virginians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... , ... California Southern University has named Dr. Steven Beazley University President. ... as a core faculty member, teaching master’s and doctoral courses in the university’s School ... University, where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also ...
(Date:1/16/2017)... ... , ... With the Grand Opening Event planned for February 3, 2017, the ... and the general public. Built in five months by Centerpoint, the 60,000 square foot ... or pickleball courts. The space is also suitable for indoor soccer and football training. ...
(Date:1/16/2017)... New York (PRWEB) , ... January 16, 2017 ... ... SightMD today announced the addition of Victor Giamos, MD to their ... of SightMD and Managing Partner at North Shore Eye Care, a division of ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... partnership with an innovator in the wheelchair accessibility industry, BraunAbility . Incentive ... salespeople to sell wheelchair accessible vehicles. With this new incentive plan, BraunAbility plans ...
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon ... , the official journal of The American Society for Aesthetic Plastic Surgery, in ... procedure is designed to correct drooping, retracted lower eyelids, which usually result from ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... BAUDETTE, Minn. , Jan. 17, 2017 /PRNewswire/ ... ) today announced the appointment of Karen Quinn ... January 17, 2017.  Karen ... years of leadership experience in Global Regulatory Affairs, ... biologically-derived active pharmaceutical ingredients.  Dr. Quinn worked most ...
(Date:1/17/2017)... pioneer in no-touch UV disinfection has now been validated by ... for "total room ultraviolet disinfection," was the device of choice ... study which was recently published in The Lancet ... transmission of four major superbugs by a cumulative 30 percent. ... we have been committed to innovation and the science behind ...
(Date:1/16/2017)... Research and Markets has announced the addition ... to their offering. ... Global multiple myeloma drugs market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... the report considers the revenue generated from the sales of branded ...
Breaking Medicine Technology: